Halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack)
RxNorm 1301695

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1301695 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack).

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack)
AUI:7717324
View
GPCK
{1 (50000 mg) (halobetasol propionate 0.0005 mg/MG Topical Ointment) / 1 (225000 mg) (lactic acid 100 mg/ML Topical Cream) } Pack
AUI:12372578
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack)
(Atom ID: 7717324)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1301695
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7717324
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1301695
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
GPCKPrescribable

Generic Pack (GPCK):
{1 (50000 mg) (halobetasol propionate 0.0005 mg/MG Topical Ointment) / 1 (225000 mg) (lactic acid 100 mg/ML Topical Cream) } Pack
(Atom ID: 12372578)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1301695
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12372578
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
1301695
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans

Patient Education

Ammonium Lactate Topical


Ammonium lactate is used to treat xerosis (dry or scaly skin) and ichthyosis vulgaris (an inherited dry skin condition) in adults and children. Ammonium lactate is in a class of medications called alpha-hydroxy acids. It works by increasing skin hydration.
[Learn More]


Halobetasol Topical


Halobetasol topical is used to treat redness, swelling, itching, and discomfort of various skin conditions in adults and children 12 years of age and older, including plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes). Halobetasol is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
[Learn More]


* Please review the disclaimer below.